- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Chugai and Biofourmis Enter into New Partnership Focused on Data-Driven Virtual Care for Endometriosis-Related Pain
Chugai Pharmaceutical and Biofourmis have partnered to continue developing digital solutions to measure pain in patients with endometriosis using a biosensor and an AI-based algorithm. The collaboration will focus on the continued development of pain measurement technology for endometriosis patients, advancing a technology platform for real-world data-driven pain measurement, and virtual specialty care delivery for endometriosis patients in the US. The partnership will also utilize data collected during research and development and post-marketing of Chugai's investigational product for the treatment of endometriosis pain. This collaboration aims to enhance Chugai's value proposition for endometriosis patients and deliver new value to patients as part of the company's growth strategy.
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
